Skip to content
10-Q

Quarterly Report

ANI PHARMACEUTICALS INC ANIP

0001023024-25-000108

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 21.09M sh
Shares Diluted Q3 2025 · Sep 30, 2025 20.91M sh
Shares Diluted Q3 2025 · Sep 30, 2024 19.4M sh
Shares Diluted Q3 2025 · Sep 30, 2024 19.28M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $11.6M
Stock Repurchased Q3 2025 · Sep 30, 2024 $10.64M
Dividends Paid Q3 2025 · Sep 30, 2025 $1.16M
Dividends Paid Q3 2025 · Sep 30, 2024 $1.22M
Capex Q3 2025 · Sep 30, 2025 $12.59M
Capex Q3 2025 · Sep 30, 2024 $13.84M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $154.86M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $48.16M
Long Term Debt Q3 2025 · Sep 30, 2025 $297.68M
Long Term Debt Q3 2025 · Dec 31, 2024 $309.11M
Short Term Debt Q3 2025 · Sep 30, 2025 $15.24M
Short Term Debt Q3 2025 · Dec 31, 2024 $9.17M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $262.61M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $144.86M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $144.98M
Cash And Equivalents Q3 2025 · Dec 31, 2023 $221.12M
Stockholders Equity Q3 2025 · Sep 30, 2025 $505.82M
Stockholders Equity Q3 2025 · Dec 31, 2024 $403.68M
Current Liabilities Q3 2025 · Sep 30, 2025 $270.56M
Current Liabilities Q3 2025 · Dec 31, 2024 $193.68M
Total Liabilities Q3 2025 · Sep 30, 2025 $902.34M
Total Liabilities Q3 2025 · Dec 31, 2024 $855.17M
Current Assets Q3 2025 · Sep 30, 2025 $698.4M
Current Assets Q3 2025 · Dec 31, 2024 $527.68M
Total Assets Q3 2025 · Sep 30, 2025 $1.41B
Total Assets Q3 2025 · Dec 31, 2024 $1.28B
Eps Diluted Q3 2025 · Sep 30, 2025 $1.13
Eps Diluted Q3 2025 · Sep 30, 2025 $2.15
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.27
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.49
Eps Basic Q3 2025 · Sep 30, 2025 $1.19
Eps Basic Q3 2025 · Sep 30, 2025 $2.26
Eps Basic Q3 2025 · Sep 30, 2024 −$1.27
Eps Basic Q3 2025 · Sep 30, 2024 −$0.49
Sga Expense Q3 2025 · Sep 30, 2025 $76.66M
Sga Expense Q3 2025 · Sep 30, 2025 $234.96M
Sga Expense Q3 2025 · Sep 30, 2024 $79.08M
Sga Expense Q3 2025 · Sep 30, 2024 $179.92M
Rd Expense Q3 2025 · Sep 30, 2025 $12.3M
Rd Expense Q3 2025 · Sep 30, 2025 $39.4M
Rd Expense Q3 2025 · Sep 30, 2024 $10.13M
Rd Expense Q3 2025 · Sep 30, 2024 $27.94M
Net Income Q3 2025 · Sep 30, 2025 $26.62M
Net Income Q3 2025 · Sep 30, 2025 $50.85M
Net Income Q3 2025 · Sep 30, 2024 −$24.17M
Net Income Q3 2025 · Sep 30, 2024 −$8.25M
Operating Income Q3 2025 · Sep 30, 2025 $36.24M
Operating Income Q3 2025 · Sep 30, 2025 $76.33M
Operating Income Q3 2025 · Sep 30, 2024 −$20.52M
Operating Income Q3 2025 · Sep 30, 2024 $4.96M
Revenue Q3 2025 · Sep 30, 2025 $227.81M
Revenue Q3 2025 · Sep 30, 2025 $636.31M
Revenue Q3 2025 · Sep 30, 2024 $148.33M
Revenue Q3 2025 · Sep 30, 2024 $423.8M